News Sentiment

NP5 sentiment intelligence

Newron Pharmaceuticals S.p.A. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed

Weighted score 50 Balanced news tone 8 relevant articles

Exchange GER Germany

Sector Healthcare Market context

Industry Biotechnology Read-through group

Latest close 13.05 Week of 10 Jul 2026

Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 8

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-1.9% over one week, -0.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Newron Provides Update Following Type A Meeting With the FDA

Market Reaction

Balanced read

58/100 confidence

Primary event Market update 81/100 classification

One-week reaction -1.9% Price digesting

Trend fit Trend inactive -0.8% over four weeks

Fair value 22.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 0

Neutral 8

Negative 0

Relevance

Why the article matched

Direct first

Direct company coverage 8

Industry context 0

Sector context 0

Sources

Coverage mix

Publishers

Business Wire 6

Barchart.com 1

BioSpace 1

Event Lens

What the news is about

Classified themes

Market update 6

Regulatory and legal 1

Earnings 1

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape